Clinical

Roughly 1 in 20 individuals carry a genetic mutation that increases their risk for cancer, yet most remain unaware. As precision medicine advances and access to genetic testing expands, the ability to identify at-risk patients has never been more attainable.…

Every minute a stroke goes unrecognized, a patient loses an average of 2 million neurons. Yet fewer than 30% of acute ischemic stroke patients are treated within the first hour — when treatment is most effective. The gap isn’t always…

Operations leaders see the promise of AI in credentialing — faster onboarding, lower administrative burden, accelerated time to revenue. They also see the risk: AI doesn’t absorb liability. Healthcare organizations do. NCQA standards still require human oversight for committee review,…

Venous thromboembolism (VTE) is the third leading cause of cardiovascular death after heart attack and stroke, yet receives far less institutional attention than either. Nearly 900,000 Americans are affected by VTE each year, and an estimated 100,000 die annually. The…

When AI investments fail to pay off, the problem is not lack of interest or excitement. It is the challenge of integrating AI into clinical workflows, building governance structures and earning clinician trust. Radiology offers a clearer path forward. Nearly…

A person living with diabetes may see providers across endocrinology, primary care, cardiology and bariatrics, yet continuous glucose monitoring (CGM) data is often not easily available to the full care team. This guide shows how health systems can build a…

Prioritizing antimicrobial stewardship (AMS) matters now more than ever. Discover how AMR is already impacting your healthcare system—and explore effective strategies to combat it. Key Takeaways

For many health system leaders, diagnostics still sit outside the strategic conversation, viewed mainly as a clinical necessity and a cost center. This report makes the case for a different approach. It shows how Henry Ford Health began treating diagnostics…

Lipoprotein(a) testing can reveal inherited cardiovascular risk that routine cholesterol panels may miss. This clinician-focused playbook from the American Heart Association offers a practical framework for understanding when Lp(a) testing matters, how to interpret results and how to guide patient…

Picture a pilot that surpasses its savings goal within 90 days and then scales across a health system. At Ardent Health, an initial target of $32.50 per admission quickly became $97 per admission during the pilot. After expansion, average savings…